Rectal Neoplasms: Clinical Trials

2,482 trials for Rectal Neoplasms, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1093 completed, 500 unknown, 329 recruiting, 214 terminated. 782 Phase 2, 646 Not applicable, 360 Phase 1, 266 Phase 3, 23 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 2782Completed 339, Unknown 132, Recruiting 92, Terminated 81, Active not recruiting 51, Not yet recruiting 48, Withdrawn 34, Suspended 4, Enrolling by invitation 1
Not applicable646Completed 239, Unknown 159, Recruiting 114, Terminated 48, Not yet recruiting 44, Active not recruiting 24, Withdrawn 13, Enrolling by invitation 3, Suspended 2
Phase 1360Completed 205, Terminated 58, Unknown 31, Recruiting 30, Active not recruiting 18, Withdrawn 11, Not yet recruiting 5, Suspended 2
Phase 3266Completed 110, Unknown 68, Recruiting 34, Terminated 23, Active not recruiting 19, Not yet recruiting 10, Suspended 1, Withdrawn 1
Phase 423Completed 10, Unknown 5, Recruiting 3, Active not recruiting 2, Not yet recruiting 1, Terminated 1, Withdrawn 1
Early Phase 112Terminated 4, Active not recruiting 2, Recruiting 2, Completed 1, Not yet recruiting 1, Unknown 1, Withdrawn 1

Follow Rectal Neoplasms: new trials by email Literature Review of Rectal Neoplasms trials Research Report on Rectal Neoplasms

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Improving Clinic Delivery of HIV-related Anal Health Services
PEACHES 2.0 Implementation Strategies - HIV, Gonorrhea
Not applicableNot yet recruitingAlbert Einstein College of Medicine82028-02-012026-10-13
Application of Multimodal MRI in Histological Grading and Prognostic Assessment of Rectal Cancer
intravoxel incoherent motion magnetic resonance imaging - Rectal Neoplasms, Prognosis
Not yet recruitingSichuan Cancer Hospital and Research Institute4002027-11-012025-12-08
PET/MRI in Rectal Cancer
Total Neo-adjuvant Therapy, 18FDG-PET/MRI scan - Rectal Cancer
Phase 2Not yet recruitingAHS Cancer Control Alberta402027-05-012026-10-28
A Bowel Management Program (Retrograde Rectal Enema) for the Treatment of Low Anterior Resection Syndrome in Rectal Cancer Patients
Dietary Fiber, Enema Administration, Loperamide Hydrochloride - Low Anterior Resection Syndrome, Rectal Carcinoma
Not applicableRecruitingOhio State University Comprehensive Cancer Center802027-02-152026-10-06
Gemcitabine, Cisplatin, Nab-paclitaxel (GAP) and Cemiplimab for Locally Advanced Biliary Tract Cancer (BTC)
Cemiplimab - Colon and Rectal Cancer
Phase 2RecruitingColumbia University202027-01-012026-11-04
COQ10 and Vitamin E for Off-Target Radiation Toxicity
Coenzyme Q10 Cap/Tab, Vitamin E Cap/Tab - Prostate Cancer, Uterine Cancer
Phase 1 / Phase 2Not yet recruitingUniversity of Nebraska2002026-12-012026-10-08
Oral B-Complex Vitamin (B6, B9 and B12) Prevents Low Anterior Resection Syndrome in Rectal Cancer Patients With Hyperhomocysteinemia
Oral B-Complex Vitamin (B6, B9 and B12), Placebo - Low Anterior Resection Syndrome, Hyperhomocysteinemia
Not applicableNot yet recruitingQilu Hospital of Shandong University2772026-12-012026-11-10
Improving Colorectal Cancer Screening Uptake Through Education and Stool-Based Testing Outreach
Colorectal Cancer Education Materials, Cologuard test kit, Fecal immunochemical test kit - Colorectal Cancer (CRC) Screening, CRC Screening
Not applicableNot yet recruitingWashington University School of Medicine2002026-11-302026-11-05
Single Versus Double Stapling and Two Purse-String Techniques in Rectal Cancer Surgery
Double-Stapled Anastomosis, Single-Stapled Anastomosis With Intracorporeal Purse-String, Single-Stapled Anastomosis With Transanal Purse-String - Rectal Cancer
Not applicableRecruitingAlexandria University1242026-11-052026-11-10
A Study of Retifanlimab After Chemoradiation in People With Anal Cancer
Retifanlimab - Anal Squamous Cell Carcinoma, Anal Cancer
Phase 2RecruitingMemorial Sloan Kettering Cancer Center252026-11-042026-11-10
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
High Rare Dose Rectal Brachytherapy Boost - Rectal Adenocarcinoma, Rectal Cancer
Phase 2RecruitingUniversity of Colorado, Denver442026-11-012026-09-02
A Prospective, Biomarker-Stratified Phase 2 Study: β-Hydroxybutyrate as a Predictive Biomarker for Short-Course Radiotherapy Followed by Chemotherapy Plus PD-1 Inhibitor Versus Chemotherapy Alone in Locally Advanced Rectal Cancer
Short-course radiotherapy, Capecitabine, Oxaliplatin - Rectal Cancer, Radiotherapy
Phase 2Not yet recruitingTao Zhang1442026-11-012026-10-06
Swabs in Screening for HPV (SWISH)
Self-collected anal swab - Anal Cancer, Human Papilloma Virus (HPV)
Not applicableNot yet recruitingKirby Institute7002026-11-012026-08-27
Multidimensional Study Designed to Develop a Methodological Framework Based on MRI Data to Predict Pathological Complete Response (pCR) in Patients With Locally Advanced Rectal Cancer After Neoadjuvant Treatment
questionnaire completion - Rectal Cancer, Chemoradiotherapy
Not yet recruitingInstitut du Cancer de Montpellier - Val d'Aurelle1152026-11-012026-11-06
Adaptive Radiotherapy for Safe Hypofractionation
Adaptive Hypofractionated Radiotherapy, Standard-of-care Radiotherapy - Cancer, Endometrial Cancer
Phase 2Not yet recruitingCentre hospitalier de l'Université de Montréal (CHUM)2642026-11-012026-10-29
Dose-Escalated Short-Course Proton Therapy for Locally Advanced Rectal Cancer
Intensity modulated proton therapy - Locally Advanced Rectal Cancer, Rectal Adenocarcinoma
Not applicableNot yet recruitingUniversity of Aarhus302026-11-012026-10-29
T1 Colorectal Cancer After Local Excision: Decision Between Surgery and Active Surveillance (T1LDA Trial)
Additional surgery - Colorectal Cancer
Not applicableNot yet recruitingTampere University Hospital5002026-11-012026-10-28
Combining DCSZ11 With Radiation and Chemotherapy as Neoadjuvant Treatment for pMMR Locally Advanced Rectal Cancer
DCSZ11, Radiation, Capecitabine - Rectal Cancer
Phase 2Not yet recruitingSidney Kimmel Comprehensive Cancer Center at Johns Hopkins302026-11-012026-10-28
Leveraging Digital Health Solutions to Collect Patient-Reported Outcomes in Rectal Cancer
Quality of Life Surveys - Rectal Cancer, Non Metastatic Rectal Cancer
Not yet recruitingUniversity of California, San Francisco1502026-10-312026-09-09
Modified Short-Course Radiotherapy Combined With Tislelizumab and CAPOX for pMMR/MSS Rectal Cancer
node-sparing modified short-course radiotherapy, standard short-course radiotherapy - Rectal Cancer
Phase 3Not yet recruitingSir Run Run Shaw Hospital2102026-10-252026-10-28

Showing 20 of 2482. Sign in to see all of them.

Narrower conditions

Colonic Neoplasms (832)  ·  Colorectal Neoplasms (646)  ·  Anus Neoplasms (295)  ·  Pancreatic Neoplasms (151)  ·  Stomach Neoplasms (130)  ·  Breast Neoplasms (129)  ·  Neoplasms (124)  ·  Uterine Cervical Neoplasms (117)  ·  Neoplasm Metastasis (104)  ·  Esophageal Neoplasms (103)  ·  Lung Neoplasms (94)  ·  Carcinoma, Non-Small-Cell Lung (93)  ·  Prostatic Neoplasms (89)  ·  Urinary Bladder Neoplasms (65)

Broader conditions

Digestive System Diseases (2473)  ·  Neoplasms by Site (2473)  ·  Gastrointestinal Diseases (2472)  ·  Digestive System Neoplasms (2469)  ·  Rectal Diseases (2466)  ·  Intestinal Diseases (2464)  ·  Intestinal Neoplasms (2463)  ·  Gastrointestinal Neoplasms (2432)  ·  Neoplasms (2358)  ·  Colorectal Neoplasms (1836)  ·  Colonic Diseases (1024)  ·  Pathological Conditions, Signs and Symptoms (442)  ·  Pathologic Processes (363)  ·  Anus Diseases (294)  ·  Urogenital Diseases (290)

Interventions

Fluorouracil (292)  ·  Oxaliplatin (273)  ·  Capecitabine (247)  ·  Leucovorin (210)  ·  Radiotherapy (157)  ·  Irinotecan (152)  ·  Bevacizumab (115)  ·  Cetuximab (88)  ·  Surgical Procedures, Operative (53)  ·  Drug Therapy (50)  ·  Radiation (50)  ·  Folfox protocol (49)  ·  Neoadjuvant Therapy (47)  ·  Chemoradiotherapy (35)  ·  Chemotherapy, Adjuvant (34)

Sponsors

National Cancer Institute (NCI) (104)  ·  Memorial Sloan Kettering Cancer Center (56)  ·  Sixth Affiliated Hospital, Sun Yat-sen University (39)  ·  Alliance for Clinical Trials in Oncology (37)  ·  Sun Yat-sen University (36)  ·  M.D. Anderson Cancer Center (33)  ·  Fudan University (28)  ·  City of Hope Medical Center (27)  ·  Fox Chase Cancer Center (18)  ·  Case Comprehensive Cancer Center (17)  ·  Sahlgrenska University Hospital (17)  ·  Stanford University (17)  ·  Washington University School of Medicine (16)  ·  Amgen (15)  ·  Roswell Park Cancer Institute (15)

Countries

United States (888)  ·  China (394)  ·  France (178)  ·  United Kingdom (120)  ·  Canada (107)  ·  Italy (103)  ·  Spain (93)  ·  Germany (85)  ·  Netherlands (74)  ·  South Korea (72)  ·  Sweden (72)  ·  Denmark (66)  ·  Belgium (62)  ·  Australia (43)  ·  Switzerland (42)

Top investigators

Leonard B. Saltz, MD (8)  ·  Marwan Fakih, MD (7)  ·  Norman Wolmark, MD (7)  ·  Gina Brown (6)  ·  Nancy E. Kemeny, MD (6)  ·  Gina Brown, MD (5)  ·  Hedy L. Kindler, MD (5)  ·  Howard S. Hochster, MD (5)  ·  Smitha Krishnamurthi, MD (5)  ·  Sydney Welt, MD (5)  ·  Aimery de Gramont, MD (4)  ·  Antonino Spinelli, MD, PhD (4)

Results publications

PMID 15496622, PMID 26187751, PMID 37310167, PMID 17976611, PMID 19269519, PMID 20106720, PMID 21596621, PMID 22529255, PMID 23008301, PMID 23395398, PMID 23578724, PMID 26049686, PMID 27432930, PMID 27602924, PMID 28223062, PMID 14616164, PMID 15894098, PMID 15927411, PMID 15997446, PMID 16099600, PMID 16971718, PMID 17042060, PMID 17401014, PMID 18316791, PMID 18430910, PMID 20065174, PMID 20354531, PMID 20797891, PMID 20956625, PMID 21494121, PMID 21550216, PMID 22067400, PMID 22070868, PMID 22434245, PMID 22591948, PMID 22770982, PMID 24440473, PMID 25623323, PMID 25651787, PMID 25822672, PMID 25830422, PMID 26156652, PMID 26189067, PMID 26808342, PMID 27480145, PMID 28190762, PMID 28453692, PMID 28594719, PMID 29067426, PMID 29234923

NIH funding

P30CA033572 (15), P30CA068485 (11), P30CA015083 (10), U10CA031946 (10), U10CA032102 (10), P30CA043703 (8), U01CA121947 (8), U10CA021115 (8), U10CA180820 (8), P30CA016672 (6), 2016 (5), 2018 (5), 2019 (5), 2025 (5), P30CA006927 (5)